DIABETES: Diabetes global disadvantage

DIABETES: Vast Majority of Diabetes Patients are Disadvantaged

28 August 2018:

Of the estimated 400 million people with diabetes globally 75% live in disadvantaged regions1. The incidence and prevalence of all common types of diabetes, Type 2 diabetes, Type 1 diabetes and gestational diabetes is increasing.  The personal and socioeconomic costs are enormous.  Adverse effects of Type 1 and Type 2 diabetes related to acute complications such as increased risk of infections and extremes of glucose levels with fluid and electrolyte disturbances, malnutrition and growth retardation. Chronic complications include blood vessel and nerve damage which may lead to vision loss, kidvASney failure, amputations, heart attacks and early death.  The available medical care, drugs, devices, social and government support have a major impact on patient outcomes.  The gap between affluent and disadvantaged regions is enormous. 

In collaboration with an international network of clinicians and researchers, with the International Diabetes Federation Life For a Child Program managed by Dr Graham Ogle and with Insulin For Life CTC investigators are active in a range of global health projects in diabetes.  These include projects related to epidemiology, health economics, practical issues such as the use of traditional cooling methods for insulin, risk factor testing and management and advocacy.  


1Diabetes Atlas, International Diabetes Federation, Brussels 2017.